Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

Effects of Social and Economic Deprivation on Cancer Mortality

Cancer Epidemiology

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

Exploiting Enzymes in Cancer Diagnosis and Therapy

Investigating the Molecular Mechanisms of Cancer

What is the Tumor Microenvironment?

Assay for Monitoring and Treating Malignant Brain Tumors

What is Cancer?

CDK9 and Cancer

Cancer Pain Management

Extracellular Vesicles as Floating Cancer Biomarkers

See more featured articles »

Transforming Cancer Care through Genomic Testing

Metastatic Migration in Cancer may be Influenced by Metabolism

The Biochemistry of Breast Cancer Screening

Cancer History

Using Biomarkers to Detect Cancer

Cancer Screening Considerations: Balancing the Benefits and Risks

What is Merkel Cell Carcinoma?

Myc Mutations and Cancer

Cancer Classification

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

What is Cancer of Unknown Primary?

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

Insights into Oncofertility

Cancer Research

Cancer Pathophysiology

What is Tumorigenesis?

Living with Cancer Pain

What Causes Cancer?

Cancer Management

What is Immunochemotherapy?

Cancer Prevention: Lowering your Risk

What Role do Biobanks Play in Cancer Research?

Cancer Glossary

Secondary Brain Cancer

Secondary Lung Cancer

Why are Cancer Cell Lines Useful?

Microfluidic cancer treatment screen combined with flow cytometry

The Effects of Cancer on Family Life

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Targeted Cancer Therapies

The Cancer Cell Surface Proteome as a Therapeutic Target

Overview of Cell Viability and Cytotoxicity

Cancer Symptoms

Cancer Prognosis

Acidosis and Tumor Progression

Insight into Cancer Vaccines

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

Caring for a Loved One with Cancer

British Pioneers in Cancer Biology

Hot vs Cold: the differences between tumor types

TARDIS: The Improved Method of Detecting Breast Cancer

Hypoxia Markers and Their Importance

Pediatric Cancer

Cutaneous Manifestations of Internal Malignancy

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

Is Cancer a Metabolic Disorder?

Cancer Diagnosis

Cancer Pain

Latest Cancer News and Research

Researchers isolate intact tumor microRNAs using antibody-conjugated nanowires

A research team in Japan has developed an efficient and minimally invasive cancer detection device that uses high-performance zinc oxide nanowires to selectively capture extracellular vesicles (EVs) from bodily fluids.

11 Jun 2026

One drink a day may be the new upper limit for safer alcohol guidance

A US cause-specific modeling study found no net protective health effect from low-level alcohol consumption, with lifetime alcohol-attributable mortality risk rising above 1 in 1,000 at just over 6.5 drinks per week for males and 7.0 drinks per week for females.

11 Jun 2026

Low-methionine diet shows promise against aggressive brain tumors

An unexpected lab observation led a team of scientists to discover how diet can influence survival in animal models of glioma, one of the most aggressive and deadly forms of brain cancer.

10 Jun 2026

Study identifies an important driver of inflammatory bowel disease

Researchers at the Nuffield Department of Medicine, University of Oxford, together with Newcastle University's Translational and Clinical Research Institute and the Department of Immunology at Cambridge University Hospitals NHS Foundation Trust, have identified an important driver of inflammatory bowel disease (IBD).

10 Jun 2026

Silver nanoparticles enable precise DNA cutting and assembly

DNA is composed of long chains that act as the blueprint for living organisms. In genetic engineering, scientists cut DNA at specific sites and join the resulting fragments to other DNA sequences, enabling applications such as advanced crop breeding, genetic disease treatment, and the generation of animal models for drug discovery.

10 Jun 2026

New DNA tetrahedron nanostructures improve targeted cancer therapy delivery

Conventional cancer treatments, such as chemotherapy, often lack specificity and can damage both cancerous and healthy cells, leading to severe side effects.

10 Jun 2026

Automated self-driving labs accelerate the search for new medicines

The Acceleration Consortium (AC) at the University of Toronto and the Structural Genomics Consortium (SGC) announced today a formalized partnership to help tackle a persistent challenge in biomedicine and early drug discovery: the development of bioactive molecules with drug-like properties, advancing our understanding of human health and disease and jump-starting new drug discovery programs.

10 Jun 2026

Tranexamic acid reduces surgical transfusions without raising clot risks

A landmark clinical trial published in the prestigious New England Journal of Medicine found that tranexamic acid reduced transfusions across major surgeries without increasing the risk of dangerous blood clots.

10 Jun 2026

New hybrid lens design drastically cuts 3D microscopy costs and complexity

A team led by Raju Tomer, professor of biological sciences at Columbia University, has created a new design for microscopes and microscope lenses that could push 3D tissue imaging beyond state-of-the-art systems while drastically cutting costs and complexity.

10 Jun 2026

Brain injury survivors face higher risk of brain cancer death

Daniel Daneshvar, MD, PhD, director of the HealthSpan Lab and Chief of the Department of Physical Medicine and Rehabilitation at Mass General Brigham, and Charlotte Luster, of the HealthSpan Lab, are the senior and lead authors of a paper published in Neuroepidemiology, "Brain Cancer Mortality following Traumatic Brain Injury (TBI): A TBI Model Systems Study."

10 Jun 2026

GSV hospitals achieve substantially higher delirium screening in older surgical patients

There is a stark gap in how often hospitals screen older adults for postoperative delirium, with verified geriatric surgery programs screening nearly every patient while non-accredited programs screen just half, according to new findings published in the Journal of the American College of Surgeons.

10 Jun 2026

Philanthropic investment expands collaborative network for autoimmune research

NYU Langone Health today announced a new philanthropic investment from longtime supporters Judy and Stewart Colton as part of a $15 million gift shared across three Colton Consortium institutions: NYU Langone, Yale University, and Tel Aviv University.

10 Jun 2026

Real-time 3D ultrasound in augmented reality helps novices perform like experts

Interpreting medical ultrasound images is a difficult task, requiring a technician to look at 2D images and mentally arrange them into a 3D representation of what the tissue looks like.

10 Jun 2026

New AI system classifies brain tumors with unprecedented accuracy

Experts in Heidelberg have developed an AI system that can classify brain tumors with unprecedented accuracy using standard microscopic tissue sections.

10 Jun 2026

Laverock Therapeutics reports key oncology research milestones

Laverock Therapeutics ('Laverock'), a biotechnology company developing disease-responsive advanced therapies through its unique, programmable gene control technology, today announced key in-vivo functional milestones across its T-cell and macrophage oncology programs for solid tumor indications.

From Laverock Therapeutics 10 Jun 2026

New meningioma atlas uncovers clues to tumor aggressiveness

One of the most detailed maps to date of meningioma - the most common brain tumor in adults - reveals how the tumor's surrounding environment helps drive disease behavior and patient outcomes, according to new research from Mayo Clinic.

9 Jun 2026

Statins may help prevent frailty in older adults

Researchers at Mass General Brigham have demonstrated that older U.S. veterans who initiated statin therapy were significantly less likely to develop frailty over time, suggesting that the cholesterol-lowering medications may have healthy aging benefits beyond cardiovascular disease prevention. Results are published in the European Heart Journal.

9 Jun 2026

Apitegromab helps tirzepatide users lose fat while preserving lean mass

A phase 2 trial found that apitegromab plus tirzepatide reduced lean body mass loss by 1.9 kg compared with tirzepatide plus placebo after 24 weeks, while overall weight loss remained similar.

9 Jun 2026

Obesity drug mazdutide reduces weight and waist size in major trial

Once-weekly 9 mg mazdutide produced clinically meaningful weight loss in Chinese adults with obesity, reducing body weight by 16.65% after 60 weeks versus 1.50% with placebo. The phase 3 GLORY-2 trial also found improvements in waist circumference, systolic blood pressure, and lipid markers, but gastrointestinal adverse events were common.

9 Jun 2026

Machine learning model filters out the biological noise in liquid biopsy samples

A machine learning model developed by researchers at the Johns Hopkins Kimmel Cancer Center filters out the biological noise in liquid biopsy samples, helping clinicians better match therapies to their patients' tumors.

9 Jun 2026